Results 111 to 120 of about 2,894 (131)
Percent of Hospitalized hMPV patients in Israel.
Percent of patients positive for hMPV infections out of patients diagnosed for respiratory virus infections. The patients were hospitalized in the Sheba Medical Center, Israel, and three winter seasons 2007–10 are presented.
Liora Regev (327469) +4 more
core +1 more source
Recent outbreaks of Human Metapneumovirus (HMPV): Prevention, Diagnosis and Therapeutic insights [PDF]
The present review aims to discuss comprehensively about the Human Metapneumovirus (HMPV) which is a respiratory pathogen belonging to the family Paramyxoviridae.
Satapathy , Abhisek +5 more
core +1 more source
Epidemiology and diagnosis technologies of human metapneumovirus in China: a mini review
Human metapneumovirus (HMPV) is a newly identified pathogen causing acute respiratory tract infections in young infants worldwide. Since the initial document of HMPV infection in China in 2003, Chinese scientists have made lots of efforts to prevent and ...
Yuan Feng +4 more
doaj +1 more source
hMPV Outbreaks: Worldwide Implications of a Re-Emerging Respiratory Pathogen
Human metapneumovirus (hMPV), a member of the Pneumoviridae subfamily, has emerged as a significant etiological agent of acute respiratory tract infections across diverse age groups, particularly affecting infants, the elderly, and immunocompromised ...
Efstathia-Danai Bikouli +10 more
core +1 more source
[Human Metapneumovirus (hMPV) associated to severe bronchial asthmatic crisis]
Human Metapneumovirus (hMPV) is a recently reported agent of acute infection in the respiratory tract. It has been found in children as well as in young adults and elders.
Tedeschi, F A +5 more
core
Some of the next articles are maybe not open access.
Related searches:
Related searches:
A Candidate Therapeutic Monoclonal Antibody Inhibits Both HRSV and HMPV Replication in Mice
Biomedicines, 2022Marie-Ève Hamelin +2 more
exaly
Development of a Novel Multi-Epitope mRNA Vaccine Candidate to Combat HMPV Virus
Human Vaccines and Immunotherapeutics, 2023Caixia Tan, Shiyang Ma, Yanhui Cui
exaly

